AUTONOMIX MEDICAL INC (AMIX)

US05330T1060 - Common Stock

6.28  -7.24 (-53.55%)

After market: 6.45 +0.17 (+2.71%)

Fundamental Rating

1

Overall AMIX gets a fundamental rating of 1 out of 10. We evaluated AMIX against 187 industry peers in the Health Care Equipment & Supplies industry. While AMIX seems to be doing ok healthwise, there are quite some concerns on its profitability. AMIX has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

In the past year AMIX has reported negative net income.

1.2 Ratios

Looking at the Return On Assets, with a value of -255.46%, AMIX is doing worse than 95.72% of the companies in the same industry.
The Return On Equity of AMIX (-342.69%) is worse than 85.03% of its industry peers.
Industry RankSector Rank
ROA -255.46%
ROE -342.69%
ROIC N/A
ROA(3y)-339.93%
ROA(5y)N/A
ROE(3y)-388.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AMIX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

The number of shares outstanding for AMIX has been reduced compared to 1 year ago.
The debt/assets ratio for AMIX is higher compared to a year ago.

2.2 Solvency

AMIX has an Altman-Z score of -11.63. This is a bad value and indicates that AMIX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -11.63, AMIX is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.20 indicates that AMIX is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.20, AMIX perfoms like the industry average, outperforming 54.01% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z -11.63
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 9.27 indicates that AMIX has no problem at all paying its short term obligations.
AMIX's Current ratio of 9.27 is amongst the best of the industry. AMIX outperforms 90.91% of its industry peers.
AMIX has a Quick Ratio of 9.27. This indicates that AMIX is financially healthy and has no problem in meeting its short term obligations.
AMIX has a Quick ratio of 9.27. This is amongst the best in the industry. AMIX outperforms 91.44% of its industry peers.
Industry RankSector Rank
Current Ratio 9.27
Quick Ratio 9.27

1

3. Growth

3.1 Past

AMIX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18089.44%.
EPS 1Y (TTM)-18089.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 13.55% on average over the next years. This is quite good.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y53.89%
EPS Next 2Y15.2%
EPS Next 3Y13.55%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMIX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMIX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

AMIX's earnings are expected to grow with 13.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.2%
EPS Next 3Y13.55%

0

5. Dividend

5.1 Amount

No dividends for AMIX!.
Industry RankSector Rank
Dividend Yield N/A

AUTONOMIX MEDICAL INC

NASDAQ:AMIX (11/22/2024, 8:23:03 PM)

After market: 6.45 +0.17 (+2.71%)

6.28

-7.24 (-53.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap7.22M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -255.46%
ROE -342.69%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 9.27
Quick Ratio 9.27
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-18089.44%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y53.89%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y